2026 NPPES data Cornea and External Diseases Specialist Physician NPI 1639528599 MD, PHD
Verify on CMS →

RIKKI ENZOR, MD, PHD

Cornea and External Diseases Specialist Physician in SACRAMENTO, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 420 beneficiaries · Cornea and External Diseases Specialist Physician avg: 1K
Generic prescribing
70%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.1 · [object Object]
Industry payments
$79.03
4 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: RIKKI ENZOR, MD, PHD is a Cornea and External Diseases Specialist Physician ([object Object]) practicing in SACRAMENTO, California with a Medicare Part D prescribing footprint of 2K claims across 420 beneficiaries — 30% brand-name prescribing . Their CMS MIPS Final Score of 100/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $79.03 across 4 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: RIKKI ENZOR, MD, PHD reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 1,732 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

RIKKI ENZOR, MD, PHD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

RIKKI ENZOR, MD, PHD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 06/10/2016

NPI 1639528599

Primary specialty

Cornea and External Diseases Specialist Physician

Rare

294 US NPIs in this specialty

Medicare Part D claims

1,732 41% vs specialty avg

2023 prescription claims

Specialty avg: 1,232

MIPS final score

100/100 16.900000000000006% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in California

How Cornea and External Diseases Specialist Physician compares to other specialties among California providers

California providers

Cornea and External Diseases Specialist Physician share within California

1. Cornea and External Diseases Specialist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cornea and External Diseases Specialist Physician share within California

Medicare quality performance — MIPS

RIKKI ENZOR, MD, PHD's 2023 MIPS final score plotted against the Cornea and External Diseases Specialist Physician national average

High performer (top quartile)
MIPS Final Score
100/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cornea and External Diseases Specialist Physician) — 100/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Cornea and External Diseases Specialist Physician) — 100/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RIKKI ENZOR, MD, PHD is a Cornea and External Diseases Specialist Physician provider practicing in SACRAMENTO, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD, PHD. NPI: 1639528599. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

RIKKI ENZOR, MD, PHD appears in the CMS NPPES registry as a Cornea and External Diseases Specialist Physician provider holding MD, PHD credentials at 4860 Y ST, SACRAMENTO, CA, 95817, with a listed phone of (916) 734-6602. NPI 1639528599 was issued on 06/10/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ENZOR most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,732 prescription claims written by this provider, covering 420 Medicare beneficiaries and totaling roughly $98K in drug spend, split 30% brand-name and 70% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 87.5432), compared with the national average of 83.1.

Cornea and External Diseases Specialist Physician is a narrow specialty nationwide, with 294 enrolled providers across 43 states and an average of 1,232 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4860 Y ST
SACRAMENTO, CA 95817

Provider Details

NPI 1639528599
Specialty Cornea and External Diseases Specialist Physician
Credentials MD, PHD
Gender Female
NPI Issued 06/10/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

100
Final Score
Avg: 83.1
87.5432
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RIKKI ENZOR, MD, PHD. Source: openpaymentsdata.cms.gov.

Total received

$79

Largest payer

Alcon Vision LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RIKKI ENZOR, MD, PHD. To verify RIKKI ENZOR, MD, PHD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RIKKI ENZOR, MD, PHD — brand share 30.0%
Specialty average (est.)

30% brand-name claims vs 70% generic, on 1,732 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,732
Total Claims
$98K
Total Drug Cost
420
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,375
Total Day Supply
63,080
Brand vs Generic
30% brand / 70% generic
Brand Drug Cost
$67K
Generic Drug Cost
$31K

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
1.31
Gender Split
59% female / 41% male
Age Distribution
<65: 32, 65-74: 191, 75-84: 151, 85+: 46

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
350
Prednisolone Acetate
274
Ketorolac Tromethamine
230
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
161
Brimonidine Tartrate
126
Timolol Maleate
106
Diclofenac Sodium
55
Erythromycin
Erythromycin Base
55
Dorzolamide Hcl
53
Rocklatan
Netarsudil Mesylat/Latanoprost
43

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cornea and External Diseases Specialist Physician Overview

How RIKKI ENZOR, MD, PHD fits within the Cornea and External Diseases Specialist Physician landscape nationally.

294
Cornea and External Diseases Specialist Physician Providers in US
43
States with Cornea and External Diseases Specialist Physician
1,232
Avg Claims per Provider

RIKKI ENZOR, MD, PHD's 1,732 claims are above the specialty average of 1,232.

Nearby Cornea and External Diseases Specialist Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as ENZOR.

Compare Cornea and External Diseases Specialist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RIKKI ENZOR, MD, PHD's specialty?
RIKKI ENZOR, MD, PHD specializes in Cornea and External Diseases Specialist Physician and practices in SACRAMENTO, California. Credentials: MD, PHD.
How much does RIKKI ENZOR, MD, PHD prescribe under Medicare Part D?
In 2023, RIKKI ENZOR, MD, PHD wrote 1,732 Medicare Part D claims totaling $98K in drug costs for 420 beneficiaries.
What is RIKKI ENZOR, MD, PHD's Medicare quality score?
RIKKI ENZOR, MD, PHD has a CMS MIPS Final Score of 100/100 (Quality: 87.5432). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RIKKI ENZOR, MD, PHD located?
RIKKI ENZOR, MD, PHD is located at 4860 Y ST, SACRAMENTO, CA, 95817. Phone: (916) 734-6602.
What is RIKKI ENZOR, MD, PHD's NPI number?
RIKKI ENZOR, MD, PHD's National Provider Identifier (NPI) is 1639528599, issued on 06/10/2016.
Does RIKKI ENZOR, MD, PHD prescribe more brand-name or generic drugs?
RIKKI ENZOR, MD, PHD's prescribing is 30% brand-name and 70% generic drugs by claim count, with $67K in brand drug costs.
How many Cornea and External Diseases Specialist Physician providers are there in the US?
There are 294 Cornea and External Diseases Specialist Physician providers across 43 states in the US. The average Cornea and External Diseases Specialist Physician provider writes 1,232 Medicare Part D claims per year.
What drugs does RIKKI ENZOR, MD, PHD prescribe most often?
Based on 2023 Medicare Part D data, RIKKI ENZOR, MD, PHD's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RIKKI ENZOR, MD, PHD accept Medicare?
RIKKI ENZOR, MD, PHD appears in CMS Medicare data with 1,732 Part D claims and 420 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RIKKI ENZOR, MD, PHD's credentials?
RIKKI ENZOR, MD, PHD's NPI is 1639528599 with credentials MD, PHD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology